ゼリア新薬工業の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2012/12/18 | 1,400 | 1,400 | 1,381 | 1,387 | -13 | -0.9% | 8,000 |
| 2012/12/17 | 1,381 | 1,400 | 1,381 | 1,400 | +33 | +2.4% | 19,000 |
| 2012/12/14 | 1,357 | 1,367 | 1,350 | 1,367 | +21 | +1.6% | 39,000 |
| 2012/12/13 | 1,380 | 1,380 | 1,335 | 1,346 | -16 | -1.2% | 19,000 |
| 2012/12/12 | 1,335 | 1,362 | 1,335 | 1,362 | +17 | +1.3% | 8,000 |
| 2012/12/11 | 1,342 | 1,345 | 1,340 | 1,345 | +16 | +1.2% | 6,000 |
| 2012/12/10 | 1,335 | 1,342 | 1,329 | 1,329 | +23 | +1.8% | 21,000 |
| 2012/12/07 | 1,293 | 1,310 | 1,293 | 1,306 | +13 | +1% | 5,000 |
| 2012/12/06 | 1,310 | 1,324 | 1,282 | 1,293 | +11 | +0.9% | 27,000 |
| 2012/12/05 | 1,273 | 1,282 | 1,273 | 1,282 | +10 | +0.8% | 10,000 |
| 2012/12/04 | 1,268 | 1,273 | 1,268 | 1,272 | +1 | +0.1% | 11,000 |
| 2012/12/03 | 1,280 | 1,280 | 1,271 | 1,271 | -5 | -0.4% | 14,000 |
| 2012/11/30 | 1,278 | 1,278 | 1,276 | 1,276 | +3 | +0.2% | 9,000 |
| 2012/11/29 | 1,274 | 1,279 | 1,265 | 1,273 | ±0 | ±0% | 14,000 |
| 2012/11/28 | 1,277 | 1,282 | 1,271 | 1,273 | +3 | +0.2% | 15,000 |
| 2012/11/27 | 1,280 | 1,283 | 1,269 | 1,270 | -8 | -0.6% | 38,000 |
| 2012/11/26 | 1,280 | 1,282 | 1,277 | 1,278 | -1 | -0.1% | 16,000 |
| 2012/11/22 | 1,282 | 1,284 | 1,272 | 1,279 | +4 | +0.3% | 12,000 |
| 2012/11/21 | 1,280 | 1,280 | 1,275 | 1,275 | +6 | +0.5% | 3,000 |
| 2012/11/20 | 1,280 | 1,280 | 1,269 | 1,269 | -15 | -1.2% | 7,000 |
| 2012/11/19 | 1,242 | 1,289 | 1,242 | 1,284 | +35 | +2.8% | 10,000 |
| 2012/11/16 | 1,230 | 1,253 | 1,222 | 1,249 | +15 | +1.2% | 17,000 |
| 2012/11/15 | 1,216 | 1,234 | 1,216 | 1,234 | +19 | +1.6% | 18,000 |
| 2012/11/14 | 1,205 | 1,226 | 1,205 | 1,215 | -7 | -0.6% | 6,000 |
| 2012/11/13 | 1,236 | 1,236 | 1,212 | 1,222 | -20 | -1.6% | 20,000 |
| 2012/11/12 | 1,240 | 1,253 | 1,227 | 1,242 | +2 | +0.2% | 20,000 |
| 2012/11/09 | 1,246 | 1,246 | 1,222 | 1,240 | -6 | -0.5% | 7,000 |
| 2012/11/08 | 1,270 | 1,270 | 1,246 | 1,246 | -21 | -1.7% | 13,000 |
| 2012/11/07 | 1,279 | 1,279 | 1,253 | 1,267 | -1 | -0.1% | 12,000 |
| 2012/11/06 | 1,280 | 1,280 | 1,267 | 1,268 | -12 | -0.9% | 6,000 |
| 2012/11/05 | 1,280 | 1,280 | 1,267 | 1,280 | -5 | -0.4% | 8,000 |
| 2012/11/02 | 1,280 | 1,292 | 1,280 | 1,285 | +11 | +0.9% | 14,000 |
| 2012/11/01 | 1,278 | 1,278 | 1,274 | 1,274 | ±0 | ±0% | 15,000 |
| 2012/10/31 | 1,241 | 1,274 | 1,241 | 1,274 | +34 | +2.7% | 17,000 |
| 2012/10/30 | 1,262 | 1,264 | 1,240 | 1,240 | -38 | -3% | 22,000 |
| 2012/10/29 | 1,260 | 1,294 | 1,260 | 1,278 | +1 | +0.1% | 15,000 |
| 2012/10/26 | 1,272 | 1,277 | 1,262 | 1,277 | +15 | +1.2% | 15,000 |
| 2012/10/25 | 1,267 | 1,268 | 1,256 | 1,262 | -11 | -0.9% | 18,000 |
| 2012/10/24 | 1,276 | 1,278 | 1,272 | 1,273 | -4 | -0.3% | 9,000 |
| 2012/10/23 | 1,275 | 1,277 | 1,272 | 1,277 | +1 | +0.1% | 16,000 |
| 2012/10/22 | 1,275 | 1,276 | 1,275 | 1,276 | +5 | +0.4% | 10,000 |
| 2012/10/19 | 1,257 | 1,277 | 1,257 | 1,271 | -5 | -0.4% | 17,000 |
| 2012/10/18 | 1,277 | 1,286 | 1,274 | 1,276 | +10 | +0.8% | 24,000 |
| 2012/10/17 | 1,260 | 1,272 | 1,260 | 1,266 | +7 | +0.6% | 22,000 |
| 2012/10/16 | 1,242 | 1,260 | 1,242 | 1,259 | +22 | +1.8% | 15,000 |
| 2012/10/15 | 1,242 | 1,242 | 1,225 | 1,237 | -15 | -1.2% | 8,000 |
| 2012/10/12 | 1,275 | 1,275 | 1,252 | 1,252 | -18 | -1.4% | 16,000 |
| 2012/10/11 | 1,252 | 1,274 | 1,252 | 1,270 | -6 | -0.5% | 17,000 |
| 2012/10/10 | 1,288 | 1,289 | 1,265 | 1,276 | -20 | -1.5% | 16,000 |
| 2012/10/09 | 1,296 | 1,300 | 1,291 | 1,296 | ±0 | ±0% | 6,000 |
3101～
3150
件表示中 / 3771件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ゼリア新薬 | 203,900円 | +3.1% | -6.5% | 2.35% | 9.46倍 | 1.00倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ジーエヌアイ | 265,600円 | +21.7% | +999.9% | 0.00% | 12.24倍 | 4.19倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 持田薬 | 313,500円 | +5.1% | -7.0% | 2.55% | 20.58倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| 栄研化 | 249,200円 | +4.1% | -3.1% | 2.33% | 21.65倍 | 1.89倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 杏林製薬 | 151,900円 | -2.4% | -52.3% | 3.75% | 18.18倍 | 0.64倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム
